Global Injection Grade Sodium Hyaluronate Market Research Report 2024(Status and Outlook)

Report Overview:

 Sodium Hyaluronate(Medical Injection Grade) is a kind of Molecular Weight

Sodium Hyaluronate Topical Grade 1.2 ~ 3.2 m3/kg. It Suitable for medical device of parenteral administration and dermal fillers. And not to be used as an API.

 This report provides a deep insight into the global Injection Grade Sodium Hyaluronate market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.

Market Value:

 The Global Injection Grade Sodium Hyaluronate Market Size was estimated at USD 245.55 million in 2023 and is projected to reach USD 327.19 million by 2029, exhibiting a CAGR of 4.90% during the forecast period.

CAGR of 4.90% (2022 – 2029)

Powder

Granules

Liquid

By Applications:

Intra-articular Injection

Ophthalmic Viscosurgical Devices (OVD)

Anti-adhesive Preparations

Soft Tissue Filler

Key players include:

• Bloomage Biotechnology Corporation Limited

• Shandong Topscience Biotech Co., Ltd.

• Lifecore Biomedical

• Compounding Chemicals

• Kangcare Bioindustry Co.,Ltd

• Shandong Runxin Biotechnology Co., Ltd

• Altergon